Skip to main content

Table 2 Patient characteristics of the eight analyzed patients (T: primary tumor stage; N1: lymph node metastases; M1: distant metastases; L0/1/x: lymphatic vessel infiltration (no/yes/no information); V0/1/x: Angioinvasion (no/yes/no information); Pn0/1/x: Perineural infiltration (no/yes/no information; unk.: unknown))

From: Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors

Patient

Age (years)

Primary tumor

Tumor staging

Size (cm)

Grading

Alive

1

66.8

small intestine

T3, N1 (50/82), M1, L1, V0, Pn1

1.3

2

yes

2

59.5

small intestine

T2, N1 (4/31), M1, L0, V0, Pn0

1.5

2

yes

3

57.0

small intestine

T4, N1 (8/28), M1, L1, V0, Pn1

1.6

2

yes

4

62.5

small intestine

T3, N1 (3/19), M1, L1, V1, Pn1

1.8

1

yes

5

47.3

small intestine

T3, N1 (5/24), M1, L1, V0, Pn0

1.5

2

yes

6

49.4

small intestine

T3, N1 (3/14), M1, L1, V0, Pn1

2.1

1

yes

7

65.9

small intestine

T4, N1 (3/16), M1, Lx, Vx, Pnx

unk.

2

no

8

72.4

small intestine

T3, N1 (5/50), M1, L1, V0, Pn0

0.8

1

yes